Articles tagged "Kidney/pancreas transplantation"

2022 American Transplant Congress
Does Dialysis Modality or Duration Influence Outcomes in Simultaneous Pancreas-Kidney Transplant Recipients?
M. Garner¹, B. Sharda², A. Farney³, J. Rogers², G. Orlando³, C. Jay⁴, A. Reeves-Daniel⁵, A. Mena-Gutierrez³, N. Sakhovskaya³, R. Stratta⁶
¹Transplant Surgery, Wake Forest Baptist Medical Center, Winston-Salem, NC, ²Wake Forest Baptist Medical Center, Winston Salem, NC, ³Wake Forest Baptist Medical Center, Winston-Salem, NC, ⁴Wake Forest Baptist Health, Winston-Salem, NC, ⁵Wake Forest University, Winston Salem, NC, ⁶Wake Forest Univ, Winston-Salem, NC
*Purpose: The influence of dialysis modality and duration on outcomes following simultaneous pancreas-kidney transplantation (SPKT) remains uncertain. The study purpose was to review our single…
2022 American Transplant Congress
Concordance of Kidney and Pancreas Rejection on Protocol and for Cause Biopsy in Simultaneous Kidney Pancreas Transplantation
P. Budhiraja, R. Heilman, H. Khamash, A. Jaramillo, D. Ramon, H. Me, J. Ninan, S. Reddy, s. S. Misra, H. Chakkera
Mayo Clinic, Phoenix, AZ
*Purpose: Our aim was to study the concordance rate of kidney and pancreas rejection in patients who received simultaneous kidney-pancreas transplantation (SKP) and its effects…
2022 American Transplant Congress
Excessive Weight Gain Does Not Associate with Poorer Graft Outcomes in Simultaneous Pancreas-Kidney Transplant Recipients – A Single-Center Experience
N. Eleti, G. Agarwal, S. Ong, C. Kew, D. Anderson, C. Young
University of Alabama at Birmingham, Birmingham, AL
*Purpose: Weight gain is common following organ transplantation, and there exists concern that in simultaneous pancreas-kidney (SPK) recipients, this may lead to poorer graft outcomes.*Methods:…
2022 American Transplant Congress
Transplant Coordinator Time Saved (TCTS) Through a Hybrid On Call Team for Deceased Donor Kidney and Pancreas Transplant Organ Offers
K. Ko, C. Gregory, J. Le, A. Lutrick, U. Reddy
Division of Kidney and Pancreas Transplantation, UC Irvine, Orange, CA
*Purpose: The purpose of this analysis was to estimate transplant coordinator time saved (TCTS) through the implementation of a hybrid on call team. Historically, transplant…
2022 American Transplant Congress
Everolimus versus Mycophenolate in Simultaneous Pancreas and Kidney Transplantation: Progression of Diabetic Retinopathy in a Prospective Randomized Trial
B. Hagerf¹, Z. Hladíková¹, M. Zahradnická¹, K. Kesslerová², T. Sosna², P. Girman¹, F. Saudek¹
¹Diabetes Centre, IKEM, Prague, Czech Republic, ²Ophtalmology Clinic, Thomayer Hospital, Prague, Czech Republic
*Purpose: mTOR inhibitors are known for their antiangiogenic effect. We compared the impact of everolimus (E) and mycophenolic acid (MPA) on the course of diabetic…
2022 American Transplant Congress
Post-Transplant Lymphoproliferative Disorder in Kidney and Simultaneous Pancreas and Kidney Transplant Recipients Predictors, and Patient and Allograft Outcomes
M. A. Mohamed¹, E. A. Yousif¹, V. Manchala², F. Aziz³, N. Garg⁴, S. Parajuli⁴, D. Mandelbrot⁵, B. Astor¹
¹Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, ²Medicine-Transplant Nephrology, University of Wisconsin School of Medicine and Public Health, Madison, WI, ³University of Wsiconsin, Madison, WI, ⁴University of Wisconsin, Madison, WI, ⁵UW Health, Madison, WI
*Purpose: Post-transplant lymphoproliferative disorder (PTLD) is a devastating complication following kidney and pancreas transplantation. 12% of UNOS waitlisted candidates had previous transplant and 20% are…
2022 American Transplant Congress
Similar Outcomes in Type 2 Diabetic vs Type 1 Diabetics Receiving Simultaneous Kidney Pancreas Transplantation
P. Budhiraja¹, H. Me¹, J. Ninan², S. Reddy², S. S. Misra¹, R. Heilman¹, H. Khamash¹, K. Reddy¹, C. Jadloweic¹, N. Katariya¹, H. Chakkera¹
¹Mayo Clinic, Phoenix, AZ, ²Mayo Clinic, Rochester, MN
*Purpose: Combined kidney-pancreas transplant remains an optimal choice for type 1 diabetics with kidney failure. The benefit for those with type 2 diabetes, however, remains…
2022 American Transplant Congress
An Initial Analysis of Baseline Levels of Dd-cfdna After Pancreas Transplantation: A Prospective Study from High-Volume Centers in the United States
A. Yoo¹, I. Qian¹, A. Riedel¹, G. Kibria¹, A. Bartosic¹, R. Soltani², O. Nduanya³, M. Omidi³, J. S. Odorico², P. L. Abrams³, M. Cooper³, J. S. Bromberg¹, J. R. Scalea¹
¹University of Maryland School of Medicine, Baltimore, MD, ²University of Wisconsin School of Medicine, Madison, WI, ³Georgetown University School of Medicine, Washington, DC
*Purpose: Donor-derived cell-free DNA (dd-cfDNA) testing, which has been validated for monitoring kidney transplant (KTx) rejection, may provide an alternative to pancreas biopsy that prevents…
2022 American Transplant Congress
Is BK After SPK Okay?: Kidney and Pancreas Transplant Outcomes After BK Viremia
G. Dube¹, K. McCune², D. Cohen³, L. Ratner², S. Husain¹
¹Columbia University Medical Center, New York, NY, ²Columbia University, New York, NY, ³Columbia University Med Ctr, New York, NY
*Purpose: BK viremia and BK nephropathy (BKN) are common after kidney transplant alone, occurring in ~15% and ~1-10%, and are associated with an increased risk…
2022 American Transplant Congress
Survival Comparison of Simultaneous Pancreas-Kidney Transplant with Pancreas After Living-Donor Kidney Transplant by Wait Time and Organ Quality
G. R. Lyden¹, E. S. Helgeson², E. B. Finger³, A. J. Matas³, J. J. Snyder⁴, D. M. Vock²
¹Scientific Registry of Transplant Recipients, Hennepin Healthcare Research Institute; Division of Biostatistics, University of Minnesota, Mpls, MN, ²Div Biostatistics U MN, Mpls, MN, ³Dept Surg U MN, Mpls, MN, ⁴Hennepin Healthcare Research Institute, Mpls, MN
*Purpose: The survival benefit of simultaneous pancreas-kidney (SPK) compared to pancreas after living-donor kidney (PALK) transplant is controversial. Wait times for SPK and donor risk…

1
2
3
…
16
Next Page »